About Us
About ToolGen
Leadership Team
Partnership
Recruit
Contact
Research&Development
R&D Program Overview
Platform Technology
Therapeutics
Greenbio Platform
Products&Services
CRISPR/Cas9 Services
Genome Editing Services
Reporter Services
In-Del Analysis Services
ToolGen’s Products
&Services Full List
News&Event
News&Event
Gallery
IR
Stock Quote
Financial Statement
Corporate filings
Customer
Notice
P&S Enquiry
Academic Library
Reference
Ordering
Research & Development
CRISPR/Cas9
Genome Editing
Therapeutics
News & Event
[보도자료] ㈜툴젠, 향상된 기능의 CAR-T 치료제(Styx-T) 연구 성과 발표
- ㈜툴젠의 면역항암제 연구성과(Styx-T), 미국 생명공학 학술지 Cancer Research 저널에 공개 - CRISPR/Cas9(3세대 유전자가위 기술)을 적용한 CAR-T ..
2018.07.04
[특집기사] 툴젠, CAR-T 'Styx-T', 면역억제환경 극복 가능성 확인
툴젠의 정인영 선임연구원이 바이오스펙테이터와의 인터뷰를 통해 연구성과에 대해 이야기하였다. 기사보러가기
2018.07.04
Products & Services
CRISPR/Cas9
Services
Genome Editing
Services
Reporter
Services
In-Del Analysis
Services
Phone
+82-2-873-8168
FAX : +82-2-873-8169
Time : Weekday 08:30 ~ 17:30
Closed on weekends and holidays
Notice
Check out new news
from Toolgen
DataRoom
Download product
documentation from Toolgen
Academic Library
Ordering
P&S enquiry
Location
